BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")
NCT03311776 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000
Last updated 2023-03-01
Summary
No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.
Conditions
Sponsors & Collaborators
-
Inna Chen, MD
lead OTHER
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-07-03
- Primary Completion
- 2035-07-02
- Completion
- 2035-07-02
Countries
- Denmark
Study Locations
More Related Trials
-
Panc CA Risk Model & Biomarker Testing In High-Risk Cohort
NCT05287347 ·Status: WITHDRAWN
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
Verification of Predictive Biomarkers for Pancreatic Cancer Treatment Using Multicenter Liquid Biopsy
NCT04241367 ·Status: COMPLETED
-
Optical and Biochemical Biomarkers in Early Pancreatic Cancer
NCT03404661 ·Status: COMPLETED
-
Plasma Biomarkers P-DAC, V1
NCT02050997 ·Status: TERMINATED
-
Pancreatic Cancer Initial Detection Via Liquid Biopsy
NCT06283576 ·Status: ENROLLING_BY_INVITATION
-
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147 ·Status: RECRUITING
-
Clinical Validation of Immunovia Next-Generation Blood Biomarker Test to Detect Early-Stage Pancreatic Cancer
NCT06947382 ·Status: COMPLETED
-
Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers
NCT04449406 ·Status: ACTIVE_NOT_RECRUITING
-
Collection of Circulating Biomarkers in Pancreatic Cancer
NCT05743049 ·Status: RECRUITING
-
A Longitudinal, Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
NCT04281511 ·Status: COMPLETED
-
AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma
NCT06320717 ·Status: RECRUITING
-
Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases
NCT02471170 ·Status: ENROLLING_BY_INVITATION
-
Observational Copenhagen Pancreatic Cancer Study
NCT06713525 ·Status: NOT_YET_RECRUITING
-
Pancreatic Cancer Biomarker Study
NCT04143152 ·Status: ACTIVE_NOT_RECRUITING
-
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
NCT05433935 ·Status: RECRUITING
-
Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma
NCT02974764 ·Status: COMPLETED
-
Characterizing the Pancreatic Cancer Proteome From Pancreatic Juice
NCT02277834 ·Status: COMPLETED
-
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
NCT01102556 ·Status: RECRUITING
-
Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer
NCT07036978 ·Status: NOT_YET_RECRUITING
-
Project Survival-Prospective Biomarker Discovery
NCT02781012 ·Status: UNKNOWN
-
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
NCT05088161 ·Status: UNKNOWN
-
Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations
NCT05687188 ·Status: RECRUITING
-
Early Detection of Pancreatic Cancer in Patients With Papillary and Mucinous Intracanal Tumours of the Pancreas Papillary and Mucinous Tumours of the Pancreas
NCT06000553 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Olaparib in Subjects With Advanced Pancreatic Acinar Cell Carcinoma
NCT05286827 ·Status: TERMINATED ·Phase: PHASE2